Unit-VII is Aurobindo Pharma's oral manufacturing facility situated at Jedcherla, Hyderabad. It is ultra-modern unit based on the suite manufactu…
Read moreIn November 2015, the company said it had received a warning letter from the US Food and Drug Administration (USFDA) for three of its sites -- acti…
Read moreHyderabad: Dr. Reddy's Laboratories Ltd on Wednesday said it has received an Establishment Inspection Report (EIR) from the US Food and Drug …
Read moreMUMBAI: India’s leading drug companies have had their manufacturing facilities cleared in the last 10 days by the US Food and Drug Administration (…
Read moreAs part of the all-of-America approach to fighting the COVID-19 pandemic, the U.S. Food and Drug Administration has been working with partners acr…
Read moreOn May 3, the U.S. Food and Drug Administration approved Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules for the treatment of the h…
Read moreAs per the USFDA, observations have been made after inspection of a facility in response to Form 483. An FDA Form 483 notifies the company's man…
Read moreThe information provided here is collected from different sources. We do not take responsibility of its correctness and verification. We are merely collecting and providing you the access to this data. You are advised to use it solely on your own discretion.
Reach us on social media:
Social Plugin